Peer-reviewed journal articles

  1. Gawne TJ, She Z, Khanal S. Human Trichomacy and refractive development. Accepted for publication in Vision Research.
  2. Khanal S, Paudel N. Is 0.01% Atropine Eye Drop Safe and Effective in Slowing Myopia Progression in Nepalese Children?. Nepalese Journal of Ophthalmology. 2024 Jul 1;16(1):108-10.
  3. Sanchez NC, Roig-Lopez JL, Mobley J, Khanal S. Proteomic signatures of retinal pigment epithelium-derived exosomes in myopic and non-myopic tree shrew eyes. Frontiers in Medicine. 2025;12:1523211.
  4. Horn D, Salzano AD, Jenewein EC, Weise KK, Schaeffel F, Mathis U, Khanal S. Topical review: Potential mechanisms of atropine for myopia control. Optometry and Vision Science. 2022 Dec 28:10-97.
  5. Phillips JR, Yam JC, Khanal S. Does 0.01% atropine have a place as a myopia control therapy?. Ophthalmic and Physiological Optics. 2025 Apr 9.
  6. Khanal S, Tomiyama E, Harrington S. Childhood Myopia Part I: Contemporary Treatment Options. Accepted for publication in IOVS.
  7. Khanal S, Tomiyama E, Harrington S. Childhood Myopia Part II: Treatment Mechanisms, Emerging Options, and Considerations. Accepted for publication in IOVS.
  8. Gawne TJ, Khanal S, Norton TT. An Alternative Mechanism for the Anti-Myopia Effectiveness of Diffusion Optics Technology (DOT) Lenses. Trans. Vis. Sci. Tech. 2025;14(1):15.
  9. Khanal S, Turnbull PR, Kim L, Phillips JR. Response of the human choroid to short-term changes in eyelid and periocular temperature. Clin Exp Optom. 2024 Jul 16:1-7.
  10. Davies LN, Biswas S, Bullimore M, Cruickshank F, Estevez JJ, Khanal S, Kollbaum P, Marcotte-Collard R, Montani G, Plainis S, Richdale K, Simard P, Wolffsohn JS. BCLA CLEAR presbyopia: Mechanism and optics. Cont Lens Anterior Eye. 2024 May 24:102185.
  11. Khanal S, Phillips JR. Is Recommending 0.01% Atropine for Myopia Control Clinically Meaningful? JAMA Ophthalmol. Published online February 15, 2024. doi:10.1001/jamaophthalmol.2023.6771.
  12. Salzano AD, Khanal S, Cheung NL, Weise KK, Jenewein EC, Horn DM, Mutti DO, Gawne TJ. Repeated Low-level Red-light Therapy: The Next Wave in Myopia Management? Optom Vis Sci. 2023 Dec 1;100(12):812-822.
  13. Khanal S. Is myopia a disease or just a dis-ease? Ophthalmic Physiol Opt. 2023 Jul;43(4):595-597. doi: 10.1111/opo.13145. Epub 2023 Apr 17. PMID: 37069742.
  14. Khanal S, Norton TT, Gawne TJ. Limited bandwidth short-wavelength light produces slowly-developing myopia in tree shrews similar to human juvenile-onset myopia. Vision Research. 2023; 204: 108161.
  15. Dahal M, Dahal HN, Gautam P, Shrestha JB, Khanal S. Pattern visual evoked potential and foveal sensitivity in amblyopia. Doc Ophthalmol. 2023 Oct;147(2):109-119.
  16. Khanal S, Norton TT, Gawne TJ. Amber light treatment produces hyperopia in tree shrews. Ophthalmic Physiol Opt. 2021 Aug 11.
  17. Norton TT, Khanal S, Gawne TJ. Tree shrews do not maintain emmetropia in initially-focused narrow-band cyan light. Exp. Eye Res. 2021 Mar 10:108525.
  18. Logan NS, Radhakrishnan H, Cruickshank F, Allen PM, Bandella PK, Davies LN, Hasebe S, Khanal S, Schmid KL, Vera-Diaz FA, Wolffsohn JS. IMI: Accommodation and Binocular Vision in Myopia Development and Progression. Invest. Ophthalmol. Vis. Sci. 2021;62(5):4.
  19. Khanal S, Bai Y, Ngo W, Wilson L, Barnes S, Nichols KK, Nichols JJ. Human meibum and tear film derived cholesteryl and wax esters in meibomian gland dysfunction and tear film structure. The Ocular Surface. 2022; 23:12-23.
  20. Bai Y, Ngo W, Khanal S, Nichols JJ. Characterization of the Thickness of the Tear Film Lipid Layer in Meibomian Gland Dysfunction using High-Resolution Optical Microscopy. The Ocular Surface. 2022; 24: 34-39.
  21. Turnbull P, Khanal S, Dakin S. The effect of cellphone position on driving and gaze behavior. Scientific reports. 2021 Apr 8;11(1):1-0.
  22. Ramamoorthy P, Khanal S (co-first author), Nichols JJ. Inflammatory proteins associated with contact lens-related dry eye. Contact Lens and Anterior Eye. 2021 Apr 3:101442.
  23. Khanal S, Ngo W, Wilson L, Barnes S, Nichols KK, Nichols JJ. Human meibum and tear film derived (o-acyl)-omega-hydroxy fatty acids in meibomian gland dysfunction. The Ocular Surface. 2021; 21: 118-128.
  24. Khanal S, Bai Y, Ngo W, Wilson L, Barnes S, Nichols KK, Nichols JJ. Human meibum and tear film derived (o-acyl)-omega-hydroxy fatty acids as biomarkers of tear film dynamics in meibomian gland dysfunction and dry eye disease. Invest Ophthalmol Vis Sci. 2021;62(9):13
  25. Khanal S, Paudel N, Joshi MR. Optometry in Nepal: historical perspectives. Clinical and Experimental Optometry. 2021 May 2:1-4.
  26. Khanal S, Paudel N, Adhikary R, Joshi MR. Topical Review: Optometry in Nepal-Clinical Practice, Research Advances, and Challenges. Optom Vis Sci. 2023 Feb 1;100(2):134-142.
  27. Bai Y, Ngo W, Khanal S, Nichols KK, Nichols JJ. Human precorneal tear film and lipid layer dynamics in meibomian gland dysfunction. The Ocular Surface. 2021 Mar 23:S1542-0124(21)00018-5.
  28. Khanal S, Rathod SN, Phillips JR. The acute effect of atropine eye drops on the human full-field electroretinogram. Doc Ophthalmol. 2021 Jun;142(3):315-328. Epub 2020.
  29. Kharal A, Khanal S (co-first author), Shrestha JB, Shrestha GS, Paudel N. Flash VEP in clinically stable pre-term and full-term infants. 2020;141(3):259-267.
  30. Khanal S, Phillips JR. Which low-dose atropine for myopia control? Clinical and Experimental Optometry. 2019; 103: 230-232.
  31. Khanal S, Turnbull PRK, Lee N, Phillips JR. Effect of atropine on global flash mfERG responses to retinal defocus. Invest Ophthalmol Vis Sci. 2019;1(60):218-225.
  32. Khanal S, Turnbull PRK, Vaghefi E, Phillips JR. Repeatability of arterial spin labeling MRI in measuring blood perfusion in the human eye. JMRI. 2019 Apr;49(4):966-74.
  33. Uprety S, Morjaria P, Shrestha JB, Shrestha GS, Khanal S. Refractive status in preterm infants and its relation to clinical risk factors. Optom Vis Sci. 2017 Oct 1;94(10):957-64.
  34. Khanal S, Walton M, Davey PG. Evaluation of intraocular pressure estimates obtained using an ICare rebound tonometer. Clin Exp Optom. 2017;100(2):179-83.
  35. Gnyawali S, Shrestha GS, Khanal S, Dennis T, Spencer JC. Ocular morbidity among porters at high altitudes. Nepal J Ophthalmol. 2017 Jun 20;9(1):30-6.
  36. Sitaula RK, Joshi SN, Khanal S. Surgical eye camp in a rural area of Nepal and its role in Vision 2020. Journal of Chitwan Medical College. 2017;6(2):1-5.
  37. Thapa M, Gautam P, Joshi SN, Khanal S. Antibiotic sensitivity pattern on cluster endophthalmitis caused by Gram-negative organism JIOM. 2017;39(2): 38-42.
  38. Khanal S, Davey PG, Racette L, Thapa M. Comparison of retinal nerve fiber layer and macular thickness for discriminating Primary Open Angle Glaucoma and Normal-Tension Glaucoma using Optical Coherence Tomography. Clin Exp Optom. 2016;99(4):373-81.
  39. Uprety S, Khanal S, Morjaria P, Puri LR. Profile of Pediatric Low Vision Population: A Retrospective Study from Nepal. Clin Exp Optom. 2016;99(1):61-5.
  40. Khanal S, Davey PG, Racette L, Thapa M. Intraeye retinal nerve fiber layer and macular thickness asymmetry measurements for the detection of Primary Open Angle Glaucoma and Normal-Tension Glaucoma using OCT. J Optom. 2016;9:118-25.
  41. Khanal S, Pokharel A, Kandel H. Visual deficits in Nepalese patients with oculocutaneous albinism. J Optom. 2016;9:102-9.
  42. Khanal S, Thapa M, Racette L, Johnson R, Davey PG, Joshi MR, Shrestha GS. Retinal nerve fiber layer thickness measurements in glaucomatous Nepalese eyes and their relation with visual field sensitivity. J. Optom. 2014;7:217-224.
  43. Khanal S, Kandel H. Axial length and corneal curvature in anisometropic amblyopia in Nepalese children. Opt Vis Perf 2014;2(3):142-145.
  44. Thapa M, Khanal S, Shrestha GB, Sharma AK. Retinal nerve fiber layer thickness measurement in Nepalese population by optical coherence tomography. Nepal J Ophthalmol 2014;6(12):131-139.
  45. Khanal S, Lama P. Profile of low vision population attending low vision clinic in a peripheral eye hospital in Nepal. Opt Vis Perf 2013;1(6):367-376.
  46. Khanal S, Gautam P, Paudel N. Waardenburg syndrome: A report of two familial case series. Opt Vis Perf 2013;1(6):378-385.
  47. Thapa M, Kumar P, Khanal S, Shrestha GB, Sharma AK. Unusual case of bilateral angle-closure glaucoma. J Nepal Med Assoc 2013;52 (190):205-12.
  48. Thapa M, Shrestha GB, Sharma AK, Karki S, Khanal S. Recurrence of uveal malignant melanoma: a case report. Nepal J Ophthalmol 2013;5(10):275-278.

Invited papers

  1. Khanal S, Tomiyama E, Harrington S. Commissioned Paper: Treatment of Childhood Myopia. Available at https://nap.nationalacademies.org/resource/27734/Khanal_et_al_Treatment_of_Childhood_Myopia.pdf submitted to the National Academies of Sciences, Engineering, and Medicine. 2024. Myopia: Causes, Prevention, and Treatment of an Increasingly Common Disease. Washington, DC: National Academies Press. https://doi.org/10.17226/27734.
  2. Davies LN, Biswas S, Bullimore M, Cruickshank F, Estevez JJ, Khanal S, Kollbaum P, Marcotte-Collard R, Montanii G, Plainis S, Richdale K, Simard P, Wolffsohn JS. BCLA CLEAR Presbyopia – Mechanism and Optics. Cont Lens Anterior Eye. 2024 May 24:102185.
  3. Logan NS, Radhakrishnan H, Cruickshank F, Allen PM, Bandella PK, Davies LN, Hasebe S, Khanal S, Schmid KL, Vera-Diaz FA, Wolffsohn JS. IMI: Accommodation and Binocular Vision in Myopia Development and Progression. Invest. Ophthalmol. Vis. Sci. 2021;62(5):4.

Editor-reviewed articles

  1. Khanal S. Repeated low-level “laser” red light therapy for childhood myopia. Mastering Myopia, Contact Lens Spectrum. February 7, 2024.
  2. Khanal S. Combination treatment strategy for myopia control. Mastering Myopia, Contact Lens Spectrum. May 18, 2022.
  3. Khanal S. Not all myopias are the same. Mastering Myopia, Contact Lens Spectrum. April 20, 2022.
  4. Khanal S. Myopia—Not Just “Nearsightedness” But a Disease. Mastering Myopia, Contact Lens Spectrum. September 15, 2021.
  5. Khanal S. Myopia Management: A Specialty or Primary Care? Mastering Myopia, Contact Lens Spectrum. July 21, 2021.
  6. Khanal S. Ocular Growth Charts: A New Decision-Making Tool For Myopia Management. Mastering Myopia, Contact Lens Spectrum. June 23, 2021.
  7. Khanal S. Evidence-based Myopia Management: Clinical Considerations. MiVision. December 2020. (Continuing Professional Development Article)
  8. Khanal S. 0.01% Atropine’s puzzling disconnect. MiVision. February 2020.
  9. Khanal S. Which low-dose atropine for myopia control? NZOptics. March 2020.
  10. Khanal S. Optometry from New Zealand to Nepal. NZAO TVC. February 2020.